Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors
Novartis
Novartis
Kivu Bioscience Inc.
Bayer
Genentech, Inc.
AstraZeneca
BeOne Medicines
Exelixis
Bayer
MOMA Therapeutics
SystImmune Inc.
Astellas Pharma Inc
Incyte Corporation
Kura Oncology, Inc.
Boehringer Ingelheim
Zymeworks BC Inc.
Hoffmann-La Roche
Novartis
AbbVie
Zhejiang Doer Biologics Co., Ltd.
Eli Lilly and Company
Iambic Therapeutics, Inc
Nammi Therapeutics Inc
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Janssen Research & Development, LLC
Janssen Research & Development, LLC
RayzeBio, Inc.
EvolveImmune United, Inc
Plexium, Inc.
Ascentage Pharma Group Inc.
OncoC4, Inc.
Compass Therapeutics
Pfizer
Revolution Medicines, Inc.
Novartis
Exscientia AI Limited
USWM, LLC (dba US WorldMeds)
Seagen Inc.
Seagen Inc.
Seagen Inc.
Vividion Therapeutics, Inc.
Seagen Inc.
Pfizer
Pfizer
Fate Therapeutics
Coherus Oncology, Inc.
Conjupro Biotherapeutics, Inc.
PanTher Therapeutics
Alterome Therapeutics, Inc.
IDEAYA Biosciences
AstraZeneca